Home›Search›Регуляторные исследования и экспертиза лекарственных средств

Регуляторные исследования и экспертиза лекарственных средств

Federal State Budgetary Institution ‘Scientific Centre for Expert Evaluation of Medicinal Products’ of the Ministry of Health of the Russian Federation (FSBI ‘SCEEMP’) · Russian Federation · Est. 2020

ISSN3034-3062eISSN3034-3453

✓ DOAJ✓ Open Access

H-Indexi

Total Worksi

135

Total Citationsi

2yr Mean Citednessi

0.67

Open Impact Factor alternative

Aims & Scope✦ Inferred from recent articles

This journal focuses on the regulatory aspects of drug development and quality control. It examines pharmacopoeial standards, analytical method development and validation, and the assessment of drug quality for both active pharmaceutical ingredients and finished medicinal products. The scope includes the harmonization of international and regional pharmacopoeial requirements, as well as the evaluation of preclinical and clinical trial data.

AI-summarised from recent articles · verify on publisher page →

General Information

Country / RegionRussian Federation

Primary LanguageRussian

1st Year Published2020

Annual Volume~ 40 articles / year

StatusActive (last: 2025)

Total Publications135

OA Since2023

Visit Journal Website

Submission Info

Peer ReviewDouble anonymous peer review

OA LicenseCC BY

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

Think.Check.Submit Compliance

thinkchecksubmit.org

8/11 · 73%

✅

Do you know the journal / publisher?

Federal State Budgetary Institution ‘Scientific Centre for Expert Evaluation of Medicinal Products’ of the Ministry of Health of the Russian Federation (FSBI ‘SCEEMP’)

✅

Does the journal have a website?

✓ Linked

✅

Is the ISSN verified?

3034-3062 / 3034-3453

✅

Indexed in a trusted database?

DOAJ

✅

Peer review process documented?

Double anonymous peer review

❌

Follows ethical publishing standards (COPE)?

N/A

✅

Not on predatory/blacklists?

✓ Clean

❌

Long-term digital preservation?

N/A

❌

Plagiarism detection in place?

N/A

✅

Listed in DOAJ (verified OA)?

DOAJ verified

✅

Primary language documented?

Russian

A twelfth criterion — whether APC fees are clearly disclosed — is not scored here; it is left out of the total rather than counted as a failure. Publication charges appear in the metrics card above.

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published

Citations received

2016

2017

2019

2020

2021

2024

2025

2026

Source: OpenAlex · Each year’s green bar = citations earned by that year’s papers, counted to date — so recent years look lower simply because their papers haven’t had time to be cited yet.

Subject Classification

Research Topics (OpenAlex)

Biosimilars and Bioanalytical MethodsSafe Handling of Antineoplastic DrugsAnalytical Methods in PharmaceuticalsPharmaceutical studies and practicesPharmaceutical Quality and CounterfeitingProtein purification and stabilityRadiopharmaceutical Chemistry and ApplicationsPharmaceutical Economics and PolicyComputational Drug Discovery MethodsAnalytical Chemistry and Chromatography

Frequently asked questions about Регуляторные исследования и экспертиза лекарственных средств

Is Регуляторные исследования и экспертиза лекарственных средств a predatory journal?

PubScope has no integrity flags on record for Регуляторные исследования и экспертиза лекарственных средств: it is indexed in DOAJ, and is not on DOAJ's withdrawn list. Indexing is a transparency signal, not a guarantee — always confirm fit and policies before submitting.

What is the impact factor of Регуляторные исследования и экспертиза лекарственных средств?

Регуляторные исследования и экспертиза лекарственных средств is not in the Web of Science Core Collection, so it has no official Clarivate Journal Impact Factor. Its open 2-year mean citedness is 0.67.

Is Регуляторные исследования и экспертиза лекарственных средств indexed in Scopus and Web of Science?

Регуляторные исследования и экспертиза лекарственных средств is indexed in DOAJ.